AbstractRecombinant lentiviral vectors pseudotyped with heterologous HIV-1 envelope glycoproteins allow rapid and accurate measurement of antibody-mediated HIV-1 neutralization. However, the neutralization phenotypes of envelope pseudoviruses have not been directly compared to isogenic replication competent HIV-1. We produced pseudoviruses expressing three different HIV-1 envelope glycoproteins and subcloned the same three env genes into a replication competent NL4-3 molecular clone. For each of the antibodies tested, the neutralization dose–response curves of pseudoviruses and corresponding replication competent viruses were similar. Thus, envelope pseudoviruses can be used to study the anti-HIV-1 neutralizing antibody response. A single p...
Standardized assays to assess vaccine and antiviral drug efficacy are critical for the development o...
OBJECTIVE: Using clinical isolates from a recent passive immunization trial with antibody 2G12, we p...
AbstractThe elicitation of broadly neutralizing antibodies directed against the human immunodeficien...
AbstractRecombinant lentiviral vectors pseudotyped with heterologous HIV-1 envelope glycoproteins al...
AbstractIn this study, progeny viruses of four HIV-1 molecular clones were tested for sensitivity to...
The absence of an effective humoral response contributes to the failure of controlling HIV-1 infecti...
AbstractNeutralization properties of human immunodeficiency virus (HIV-1) are often defined using ps...
ABSTRACT Recently discovered broadly neutralizing antibodies (bNAbs) against HIV-1 demonstrate exten...
AbstractEndoproteolytic processing of the human immunodeficiency virus type 1 (HIV-1) envelope (Env)...
<div><p>Standardized assays to assess vaccine and antiviral drug efficacy are critical for the devel...
AbstractIn this study, we tested the hypothesis that donors with broadly cross-reactive HIV-1 neutra...
AbstractCultured primary peripheral blood mononuclear cells (PBMC) represent a potentially physiolog...
AbstractWe constructed a number of HXB2 viruses chimeric for the gp120 glycoprotein derived from a n...
AbstractAdaptation of antibody neutralization-resistant human immunodeficiency virus type I (HIV-1) ...
In this study, we tested the hypothesis that donors with broadly cross-reactive HIV-1 neutralizing (...
Standardized assays to assess vaccine and antiviral drug efficacy are critical for the development o...
OBJECTIVE: Using clinical isolates from a recent passive immunization trial with antibody 2G12, we p...
AbstractThe elicitation of broadly neutralizing antibodies directed against the human immunodeficien...
AbstractRecombinant lentiviral vectors pseudotyped with heterologous HIV-1 envelope glycoproteins al...
AbstractIn this study, progeny viruses of four HIV-1 molecular clones were tested for sensitivity to...
The absence of an effective humoral response contributes to the failure of controlling HIV-1 infecti...
AbstractNeutralization properties of human immunodeficiency virus (HIV-1) are often defined using ps...
ABSTRACT Recently discovered broadly neutralizing antibodies (bNAbs) against HIV-1 demonstrate exten...
AbstractEndoproteolytic processing of the human immunodeficiency virus type 1 (HIV-1) envelope (Env)...
<div><p>Standardized assays to assess vaccine and antiviral drug efficacy are critical for the devel...
AbstractIn this study, we tested the hypothesis that donors with broadly cross-reactive HIV-1 neutra...
AbstractCultured primary peripheral blood mononuclear cells (PBMC) represent a potentially physiolog...
AbstractWe constructed a number of HXB2 viruses chimeric for the gp120 glycoprotein derived from a n...
AbstractAdaptation of antibody neutralization-resistant human immunodeficiency virus type I (HIV-1) ...
In this study, we tested the hypothesis that donors with broadly cross-reactive HIV-1 neutralizing (...
Standardized assays to assess vaccine and antiviral drug efficacy are critical for the development o...
OBJECTIVE: Using clinical isolates from a recent passive immunization trial with antibody 2G12, we p...
AbstractThe elicitation of broadly neutralizing antibodies directed against the human immunodeficien...